Immediate Impact
48 standout
Citing Papers
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
2024 Standout
Long-Term Outcomes in IgA Nephropathy
2023 Standout
Works of Keng-Thye Woo being referenced
Global Evolutionary Trend of the Prevalence of Primary Glomerulonephritis over the Past Three Decades
2010
ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Keng-Thye Woo | 143 | 96 | 57 | 12 | 207 | |
| Sarah Seiler-Mußler | 98 | 51 | 18 | 13 | 207 | |
| Hong‐Mou Shih | 97 | 46 | 24 | 15 | 265 | |
| Bastiaan van Dam | 102 | 116 | 12 | 12 | 292 | |
| Heloísa Reniers Vianna | 44 | 91 | 48 | 9 | 200 | |
| S Rekola | 218 | 33 | 22 | 9 | 295 | |
| Weston M. Kelsey | 63 | 79 | 15 | 13 | 268 | |
| Filippo Mangione | 110 | 36 | 12 | 16 | 261 | |
| Maarten A. de Jong | 176 | 33 | 55 | 11 | 281 | |
| Ari Lieber | 52 | 194 | 28 | 13 | 288 | |
| Tsutomu Mano | 163 | 100 | 53 | 13 | 297 |
All Works
Loading papers...